Exploring Analyst Estimates for Intuitive Surgical (ISRG) Q4 Earnings, Beyond Revenue and EPS

17.01.25 15:15 Uhr

Werte in diesem Artikel
Aktien

577,10 EUR 11,80 EUR 2,09%

Indizes

PKT PKT

21.441,2 PKT 349,9 PKT 1,66%

19.630,2 PKT 291,9 PKT 1,51%

5.996,7 PKT 59,3 PKT 1,00%

Wall Street analysts forecast that Intuitive Surgical, Inc. (ISRG) will report quarterly earnings of $1.76 per share in its upcoming release, pointing to a year-over-year increase of 10%. It is anticipated that revenues will amount to $2.41 billion, exhibiting an increase of 25.2% compared to the year-ago quarter.The current level reflects an upward revision of 0.6% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.With that in mind, let's delve into the average projections of some Intuitive Surgical metrics that are commonly tracked and projected by analysts on Wall Street.Analysts predict that the 'Revenue- Product (Instruments and accessories and Systems)' will reach $1.82 billion. The estimate suggests a change of +12.4% year over year.The consensus among analysts is that 'Revenue- Services' will reach $343.90 million. The estimate indicates a year-over-year change of +13%.It is projected by analysts that the 'Revenue- Systems' will reach $484.93 million. The estimate points to a change of +1% from the year-ago quarter.According to the collective judgment of analysts, 'Revenue- Instruments and accessories' should come in at $1.34 billion. The estimate suggests a change of +17.2% year over year.The combined assessment of analysts suggests that 'Total System Units Placed - Total Company' will likely reach 427. The estimate is in contrast to the year-ago figure of 415.Analysts expect 'Da Vinci Surgical System Installed Base' to come in at 9,931. Compared to the current estimate, the company reported 8,606 in the same quarter of the previous year.Analysts forecast 'Total System Units Placed - Outside of the United States' to reach 207. Compared to the current estimate, the company reported 206 in the same quarter of the previous year.Based on the collective assessment of analysts, 'Total System Units Placed - United States' should arrive at 208. Compared to the current estimate, the company reported 209 in the same quarter of the previous year.The collective assessment of analysts points to an estimated 'Gross profit- Service' of $229.90 million. Compared to the current estimate, the company reported $214.80 million in the same quarter of the previous year.Analysts' assessment points toward 'Cost of revenue- Service' reaching $106.97 million. The estimate compares to the year-ago value of $89.60 million.View all Key Company Metrics for Intuitive Surgical here>>>Shares of Intuitive Surgical have demonstrated returns of +11.5% over the past month compared to the Zacks S&P 500 composite's -2.1% change. With a Zacks Rank #3 (Hold), ISRG is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Just Released: Zacks Top 10 Stocks for 2025Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intuitive Surgical, Inc. (ISRG): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Intuitive Surgical

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Intuitive Surgical

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Intuitive Surgical Inc

Wer­bung

Analysen zu Intuitive Surgical Inc

DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
19.07.2019Intuitive Surgical BuyCanaccord Adams
22.04.2019Intuitive Surgical BuyCanaccord Adams
02.04.2019Intuitive Surgical BuyDeutsche Bank AG
19.10.2018Intuitive Surgical BuyCanaccord Adams
18.04.2018Intuitive Surgical BuyCanaccord Adams
DatumRatingAnalyst
26.01.2018Intuitive Surgical HoldCanaccord Adams
18.07.2017Intuitive Surgical Sector PerformRBC Capital Markets
30.06.2017Intuitive Surgical NeutralCantor Fitzgerald
30.05.2017Intuitive Surgical HoldCanaccord Adams
17.04.2017Intuitive Surgical Sector PerformRBC Capital Markets
DatumRatingAnalyst
23.01.2015Intuitive Surgical SellCRT Capital
22.10.2014Intuitive Surgical SellCRT Capital
09.01.2009Intuitive Surgical DowngradeBrean Murray, Carret & Co., LLC
26.08.2005Update Intuitive Surgical Inc. : UnderperformJefferies & Co

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Intuitive Surgical Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"